Legacy Wealth Management (Idaho)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-250
Closed -$1.85K 668
2026
Q1
$1.85K Hold
250
﹤0.01% 789
2025
Q4
$2.94K Hold
250
﹤0.01% 618
2025
Q3
$1.93K Hold
250
﹤0.01% 547
2025
Q2
$1.83K Hold
250
﹤0.01% 527
2025
Q1
$2.37K Hold
250
﹤0.01% 516
2024
Q4
$3.36K Hold
250
﹤0.01% 434
2024
Q3
$4.11K Buy
+250
New +$3.91K ﹤0.01% 406

Other funds holding NEO

Legacy Wealth Management (Idaho)'s NEO Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 250 shares — an estimated $1.85K sold.

Legacy Wealth Management (Idaho) first reported a position in NEO in Q3 2024 and held it in 7 quarters. The position peaked at $4.11K in Q3 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 250 NeoGenomics shares in Q2 2026, an estimated $1.85K.
  • Legacy Wealth Management (Idaho) first reported a position in NeoGenomics in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s NeoGenomics position peaked at $4.11K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.